Silica exposure and systemic vasculitis

Environmental Health Perspectives

Volumn 111, Issue 16, 2003, Pages 1933-1938

  Mulloy, Karen B ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Crystalline silica; Department of Energy workers; Energy Employees Occupational Illness Compensation Program; Nevada test site; Systemic vasculitis

Indexed keywords

ACETONE; ASBESTOS; BERYLLIUM; CARBON TETRACHLORIDE; CREATININE; CYCLOPHOSPHAMIDE; EPOXIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HEAVY METAL; KETONE DERIVATIVE; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NITRIC ACID; PREDNISONE; SILICON DIOXIDE; SOLVENT; URANIUM;

ACUTE DISEASE; ADULT; ARTHRALGIA; ARTICLE; AUTOIMMUNE DISEASE; BERYLLIOSIS; BLOOD ANALYSIS; CASE REPORT; CHRONIC DISEASE; CREATININE BLOOD LEVEL; CRYSTAL STRUCTURE; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; GLOMERULONEPHRITIS; GOVERNMENT; HEMATURIA; HUMAN; IDIOPATHIC DISEASE; IONIZING RADIATION; KIDNEY BIOPSY; LEUKOCYTOCLASTIC VASCULITIS; MALE; NECROTIZING ARTERITIS; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RADIATION EXPOSURE; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RHEUMATOID ARTHRITIS; SCLERODERMA; SILICOSIS; SKIN BIOPSY; SKIN MANIFESTATION; SMALL VESSEL VASCULITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; WORKMAN COMPENSATION;

GLOMERULUS; SCLERODERMA;

EID: 0347382422     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6400     Document Type: Article

References (47)

1. American Thoracic Society Committee of the Scientific Assembly on Environmental and Occupational Health. 1997. Adverse effects of crystalline silica exposure. Am J Respir Crit Care Med 155:761-768.
2. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, et al. 2003. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 41:776-784.
3. Calvert GM, Steenland K, Palu S. 1997. End-stage renal disease among silica-exposed gold miners. JAMA 277:1219-1223.
4. Caplan A. 1953. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 8:29-35.
5. Churg A. 1998. Nonneoplastic disease caused by asbestos. In: Pathology of Occupational Lung Disease (Churg A, Green FHY, eds). 2nd ed. Baltimore, MD:Williams & Wilkins, 277-338.
6. Danning CL, Illei GG, Boumpas DT. 1998. Vasculitis associated with primary rheumatologic diseases. Curr Opin Rheumatol 10:58-65.
7. D'Cruz D. 2000. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 112-113:421-432.
8. Dick JA, Morgan WKC, Muir DFC, Reger RB, Sargent N. 1992. The significance of irregular opacities on the chest roentgenogram. Chest 102:251-260.
9. DOE. 2000. Energy Employees Occupational Illness Compensation Program Act of 2000 (EEOICPA). Fact Sheet. Washington, DC:U.S. Department of Energy. Available: http://tis.eh.doe.gov/portal/feature/Factsheet2000.pdf [accessed 12 March 2003].
10. DOE Nevada. 2003. Photo Library. Las Vegas, NV:Department of Energy, Nevada Operations Office. Available: http://www.nv.doe.gov/news&pubs/photos&films/photolib.htm [accessed 20 October 2003].
11. DOE Office of Worker Advocacy. 2003. EEOICP Claims Status. Washington, DC:U.S. Department of Energy. Available: http://tis.eh.doe.gov/advocacy/whatshot/20030311programstats.pdf [accessed 5 September 2003].
12. Gibbs AR, Wagner JC. 1998. Diseases due to silica. In: Pathology of Occupational Lung Disease (Churg A, Green FHY, eds). 2nd ed. Baltimore, MD:Williams & Wilkins, 209-233.
13. Gregorini G, Ferioli A, Donato F, Tira P, Morassi L, Tardanico R, at al. 1993. Association between silica exposure and necrotizing crescentic glomerulonephritis with pANCA and anti-MPO antibodies: a hospital-based case-control study. Adv Exp Med Biol 336:435-440.
14. Gregorini G, Tira P, Frizza J, D'Haese PC, Elseviers MM, Nuyts G, et al.1997. ANCA-associated diseases and silica exposure. Clin Rev Allergy Immunol 15:21-40.
15. Gonzales-Gay MA, Garcia-Porrua C. 2001. Epidemiology of the vasculitides. Rheum Dis Clin North Am 27:729-749.
16. Honma K, Chiyotani K. 1993. Diffuse interstitial fibrosis in non-asbestos pneumoconiosis-a pathological study. Respiration 60:120-126.
17. Jones RN, Turner-Warwick M, Ziskind M, Weill H. 1976. High prevalence of antinuclear antibodies in sandblasters' silicosis. Am Rev Respir Dis 113:393-395.
18. Kamesh L, Harper L, Savage CO. 2002. ANCA-poshive vasculitis. J Am Soc Nephrol 13:1953-1960.
19. Klockars M, Koskela RS, Jarvinen E, Kolari PJ, Rossi A. 1987. Silica exposure and rheumatoid arthritis: a follow up study of granite workers 1940-81. Br Med J 294:997-1000.
20. Koeger A-C, Lang T, Alcaix D, Milleron B, Rozenberg S, Chaibi P, et al. 1995. Silica-associated connective tissue disease. Medicine 74:221-237.
21. Langford CA. 2003. Vasculitis. J Allergy Clin Immunol 111(2 suppl):S602-612.
22. Lippmann M, Eckert HL, Hahon N, Morgan WK. 1973. Circulating antinuclear and rheumatoid factors in coal miners: a prevalence study in Pennsylvania and West Virginia. Ann Int Med 79:807-811.
23. Mansi IA, Opran A, Rosner F. 2002. ANCA-associated small-vessel vasculitis. Am Fam Physician 65:1615-1620.
24. Martin JR, Griffin M, Moore E, Lochead JA, Edwards AC, Williams J, et al. 1999. Systemic sclerosis (scleroderma) in two iron ore miners. Occup Med 49:161-169.
25. Mayes MD. 1999. Epidemiologic studies of environmental a gents and systemic autoimmune diseases. Environ Health Perspect 107(suppl 5):743-748.
26. Miall WE, Caplan A, Cochrane AL, Kilpatrick GS, Oldham PD. 1953. An epidemiological study of rheumatoid arthritis associated with characteristic chest x-ray appearances in coal-workers. Br Med J 11:1231-1236.
27. NIOSH. 2002. NIOSH Hazard Review - Health Effects of Occupational Exposure to Respirable Crystalline Silica. DHHS (NIOSH) Publication No. 2002-2129. Cincinnati, OH:National Institute for Occupational Safety and Health. Available: http://www.cdc.gov/niosh/02-129pd.html [accessed 20 October 2003].
28. Nowack R, Flores-Suarez LF, van der Woude FJ. 1998. New developments in pathogenesis of systemic vasculitis. Curr Opin Rheumatol 10:3-11.
29. OSHA. 2003. Regulations (Standards - 29 CFR) Table Z-3 Mineral Dusts - 1910.1000. Available: http://www.osha-slc.gov/pls/oshaweb/owadisp.show_document? p_table=STANDARDS&p_id=9994 [accessed 25 August 2003].
30. Otsuki T, Sakaguchi H, Tomokuni A, Aikoh T, Matsuki T, Kawakami Y, et al. 1998. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology 94:258--262.
31. Parks CG, Conrad K, Cooper GS.1999. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 107(suppl 5):793-802.
32. Parks CG, Cooper GS, Nylander-French LA, Sanderson WT, Dement JM, Cohen PL, et al. 2002. Occupational exposure to crystalline silica and risk of systemic lupus orythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum 46:1840-1850.
33. Pepper L, Boden L, Kozar N, Lally J, Suza K, Medina S. 1998. Medical Surveillance for Former Department of Energy Workers at the Nevada Test Site. Phase 1 Report. Needs Assessment. Boston, MA:Boston University School of Public Health.
34. Powell JJ, Van de Water J, Gershwin ME. 1999. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect 107(suppl 5):667-672.
35. Rom WN. 1998. Asbestos-related diseases. In: Environmental and Occupational Medicine (Rom WN, ed). 3rd ed. Philadelphia:Lippincott-Raven, 349-375.
36. Shida H, Chiyotani K, Honma K, Hosoda Y, Nobechi T, Morikubo H, et al. 1996. Radiologic and pathologic characteristics of mixed dust pneumoconiosis. Radiographics 16:483-498.
37. Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR. 1986. Relationship between silicosis and rheumatoid arthritis. Thorax 41:596-601.
38. Sluis-Cremer GK, Hassel PA, Nizdo EH, Churchill AR, Zeiss EA. 1985. Silica, silicosis, and progressive systemic sclerosis. Br J Ind Med 42:838-843.
39. Smith DA, Germolec DR. 1999. Introduction to immunology and autoimmunity. Environ Health Perspect 107(suppl 5):661-665.
40. Steenland K, Goldsmith DF. 1995. Silica exposure and autoimmune diseases. Am J Ind Med 28:603-608.
41. Steenland K, Sanderson W, Calvert GM. 2001. Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology 12:405-412.
42. Tervaert JWC, Stegeman CA, Kallenberg CGM. 1998. Silicon exposure and vasculitis. Curr Opin Rheumatol 10:12-17.
43. Theofilopoulos AN, Kono DH. 1998. Mechanisms and genetics of autoimmunity. Ann NY Acad Sci 841:225-235.
44. Tomokuni A, Aikoh T, Matsuki T, Isozaki Y, Otsuki T, Kita S, et al. 1997. Elevated soluble FAS/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin Exp Immunol 110:303-309.
45. Tomokuni A, Otsuki T, Isozaki Y, Kita S, Ueki H, Kusaka M, et al. 1999. Serum levels of soluble Fas ligand in patients with silicosis. Clin Exp Immunol 118:441-444.
46. U.S. Bureau of Mines. 1992. Crystalline Silica Primer. Available: http://minerals.usgs.gov/minerals/pubs/commodity/silica/780292.pdf [accessed 25 August 2003].
47. Watts RA, Scott DG. 1997. Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol 11:191-217.